The present and future of measurable residual disease testing in acute myeloid leukemia
Considerable progress has been made in the past several years in the scientific understanding of, and available treatments for, acute myeloid leukemia (AML). Achievement of a conventional remission, evaluated cytomorphologically via small bone marrow samples, is a necessary but not sufficient step...
में बचाया:
| मुख्य लेखकों: | , , |
|---|---|
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Ferrata Storti Foundation
2022-12-01
|
| श्रृंखला: | Haematologica |
| ऑनलाइन पहुंच: | https://haematologica.org/article/view/10873 |
| टैग: |
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|